Selective beta adrenergic receptor antagonism in the anesthetized dog.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to B Levy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
1. The beta-adrenoceptor blocking properties of 1-(p-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (H 64/52) on the cardiovascular and bronchomotor responses to isoprenaline have been determined in the anaesthetized dog.2. H 64/52 selectively blocked the isoprenaline-induced increase in heart rate, contractile force and reduction in airway pressure in the same dose range.3. H 64/52 produced a minimal blockade of vascular beta-adrenoceptors which was apparent only when the isoprenaline-induced fall in diastolic pressure was considered. No significant vascular beta-adrenoceptor blockade with H 64/52 could be shown with the femoral arterial flow or hind-limb perfusion studies.4. These results further support the hypothesis that several different beta-adrenoceptor subtypes exist in the dog. The beta-adrenoceptors subserving cardiac stimulation and bronchodilation appear to be similar and both differ from the beta-adrenoceptor subserving vasodilatation.
1. The beta-adrenoceptor blocking properties of alpha-methyl propranolol and alpha-methyl practolol were determined in anaesthetized dogs according to their abilities to modify the isoprenaline-induced effects on diastolic pressure, heart rate, myocardial contractile force, femoral arterial blood flow and pulmonary airway resistance.2. alpha-Methyl propranolol shifted the isoprenaline dose-response curves for the fall in diastolic pressure and the positive inotropic and chronotropic responses to the right in a parallel manner yielding pA(2) and slope values of 6.66 (0.92), 6.34 (0.77) and 6.59 (0.61) respectively. The slopes of the graphs for determining pA(2) values for the cardiac beta-adrenoceptor blocking properties of alpha-methyl propranolol were significantly less than 1 and indicated a mechanism other than simple, competitive, reversible antagonism.3. alpha-Methyl propranolol exerted a much weaker blockade of respiratory smooth muscle beta-adrenoceptors than has been reported for propranolol.4. alpha-Methyl practolol exerted a weaker blocking effect on myocardial beta-adrenoceptors than has been reported for practolol. No significant blockade of vascular or respiratory smooth muscle beta-adrenoceptors occurred after a total cumulative dose of 10 mug/kg of alpha-methyl practolol.5. alpha-Methyl substitution of propranolol and practolol reduces the potency but increases the selectivity of their beta-adrenoceptor blocking properties.6. The beta-adrenoceptors subserving cardiac stimulation, vasodilatation and bronchodilatation are representative of three different beta-adrenoceptor sub-types in the dog.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.